Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2024-12-31
• Last 15 days FTD volume: £0 M
• Last 3 months FTD volume: £0.65 M
• Last year FTD volume: £0.65 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Baxter BAX	£10.76 M	£38.81 M	🇺🇸 USA
Geron GERN	£12.06 M	£28.73 M	🇺🇸 USA
Omeros Corporation OMER	£1.51 M	£6.79 M	🇺🇸 USA
Sanofi SNY	£4.14 M	£72.79 M	🇫🇷 France
Bio-Techne TECH	£2.08 M	£29 M	🇺🇸 USA
Genetic Technologies GENE	£0 M	£1.15 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	£12.16 M	£36.72 M	🇮🇱 Israel